JP2021534165A5 - - Google Patents
Info
- Publication number
- JP2021534165A5 JP2021534165A5 JP2021507775A JP2021507775A JP2021534165A5 JP 2021534165 A5 JP2021534165 A5 JP 2021534165A5 JP 2021507775 A JP2021507775 A JP 2021507775A JP 2021507775 A JP2021507775 A JP 2021507775A JP 2021534165 A5 JP2021534165 A5 JP 2021534165A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- months
- antibody
- cancer
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862765093P | 2018-08-16 | 2018-08-16 | |
| US62/765,093 | 2018-08-16 | ||
| PCT/US2019/046467 WO2020037024A1 (en) | 2018-08-16 | 2019-08-14 | Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534165A JP2021534165A (ja) | 2021-12-09 |
| JP2021534165A5 true JP2021534165A5 (https=) | 2022-08-12 |
| JPWO2020037024A5 JPWO2020037024A5 (https=) | 2022-08-12 |
Family
ID=69525825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507775A Pending JP2021534165A (ja) | 2018-08-16 | 2019-08-14 | 抗組織因子抗体−薬物コンジュゲートおよびがんの治療におけるその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210308208A1 (https=) |
| EP (1) | EP3836950A4 (https=) |
| JP (1) | JP2021534165A (https=) |
| KR (1) | KR20210046016A (https=) |
| CN (1) | CN112584872A (https=) |
| AU (1) | AU2019321442A1 (https=) |
| BR (1) | BR112021001691A2 (https=) |
| CA (1) | CA3109116A1 (https=) |
| EA (1) | EA202190102A1 (https=) |
| IL (1) | IL280617A (https=) |
| MX (1) | MX2021001058A (https=) |
| SG (1) | SG11202101428UA (https=) |
| WO (1) | WO2020037024A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI841554B (zh) | 2018-03-21 | 2024-05-11 | 丹麥商珍美寶股份有限公司 | 以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法 |
| WO2019217455A1 (en) | 2018-05-07 | 2019-11-14 | Genmab A/S | Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate |
| TWI844571B (zh) | 2018-10-30 | 2024-06-11 | 丹麥商珍美寶股份有限公司 | 使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法 |
| WO2021200131A1 (ja) * | 2020-03-30 | 2021-10-07 | 国立研究開発法人国立がん研究センター | 抗体薬物複合体 |
| TW202210104A (zh) | 2020-06-04 | 2022-03-16 | 瑞典商生物創新國際有限公司 | 皮下抗體調配物 |
| EP3919077A1 (en) | 2020-06-04 | 2021-12-08 | BioInvent International AB | Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodies |
| AU2022238571A1 (en) | 2021-03-18 | 2023-09-14 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA109633C2 (uk) * | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
| JP6055404B2 (ja) * | 2010-06-15 | 2016-12-27 | ゲンマブ エー／エス | 組織因子に対するヒト抗体薬物結合体 |
| KR102372245B1 (ko) * | 2013-11-21 | 2022-03-08 | 젠맵 에이/에스 | 항체-약물 접합체 동결건조 제제 |
| ES2895623T3 (es) * | 2014-05-22 | 2022-02-22 | Byondis Bv | Conjugación de sitio específico de fármacos enlazadores con anticuerpos y ADC resultantes |
| HUE055109T2 (hu) * | 2015-09-11 | 2021-11-29 | Genmab As | Adagolási rendek TF elleni antitest és gyógyszer konjugátumaihoz |
| IL274122B2 (en) * | 2017-11-02 | 2024-09-01 | Genmab As | Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer |
| EP3735271A4 (en) * | 2018-01-04 | 2022-06-15 | Iconic Therapeutics, Inc. | ANTI-TISSUE FACTOR ANTIBODIES, ANTIBODY DRUG CONJUGATES AND RELATED METHODS |
-
2019
- 2019-08-14 AU AU2019321442A patent/AU2019321442A1/en not_active Abandoned
- 2019-08-14 US US17/268,387 patent/US20210308208A1/en not_active Abandoned
- 2019-08-14 WO PCT/US2019/046467 patent/WO2020037024A1/en not_active Ceased
- 2019-08-14 MX MX2021001058A patent/MX2021001058A/es unknown
- 2019-08-14 CA CA3109116A patent/CA3109116A1/en active Pending
- 2019-08-14 CN CN201980054479.8A patent/CN112584872A/zh active Pending
- 2019-08-14 SG SG11202101428UA patent/SG11202101428UA/en unknown
- 2019-08-14 KR KR1020217007245A patent/KR20210046016A/ko not_active Withdrawn
- 2019-08-14 EP EP19849100.3A patent/EP3836950A4/en not_active Withdrawn
- 2019-08-14 BR BR112021001691-0A patent/BR112021001691A2/pt unknown
- 2019-08-14 JP JP2021507775A patent/JP2021534165A/ja active Pending
- 2019-08-14 EA EA202190102A patent/EA202190102A1/ru unknown
-
2021
- 2021-02-03 IL IL280617A patent/IL280617A/en unknown